Internal Medicine, Pulmonary Disease · Las Vegas, NV
NPI
1508899253
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1707 W Charleston Blvd Ste 230
Las Vegas, NV, 89102
Phone (702) 671-5070
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
399 services
Medicare patients, 2024
181
Average age 69
Drug cost, 2024
$3.3M
584 prescriptions
Company payments, 2025
$746
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angelica E Honsberg was code 99233 (hospital e&m - subsequent), 76 times for 41 patients. In total Angelica E Honsberg billed 399 services in 31 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 76 | 41 | $91.59 | $6,961 |
| 99232 Hospital E&M - Subsequent | Facility | 56 | 37 | $59.70 | $3,343 |
| 99214 Office E&M - Established | Office | 35 | 21 | $87.51 | $3,063 |
| 99291 Critical Care E&M | Facility | 32 | 21 | $163.68 | $5,238 |
| 94060 Pulmonary Function Testing | Facility | 29 | 29 | $7.84 | $227 |
| 99222 Hospital E&M - Initial | Facility | 28 | 28 | $100.50 | $2,814 |
| 94729 Pulmonary Function Testing | Facility | 24 | 24 | $6.79 | $163 |
| 94726 Pulmonary Function Testing | Facility | 24 | 24 | $9.14 | $219 |
| 94010 Pulmonary Function Testing | Facility | 18 | 18 | $6.26 | $113 |
By year: 2022 $44K for 533 services; 2023 $31K for 450 services; 2024 $26K for 399 services.
Medicare prescription drug claims, 2024
In 2024, the drug Angelica E Honsberg prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 105 prescriptions and refills. In total Angelica E Honsberg wrote 584 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 105 | 105 | Under 11 | $2.7M |
| Montelukast Sodium Generic | 24 | 34 | Under 11 | $67.91 |
| Arnuity Ellipta Fluticasone Furoate | 24 | 24 | Under 11 | $5,352 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 23 | 23 | Under 11 | $320 |
| Spiriva Respimat Tiotropium Bromide | 22 | 22 | Under 11 | $12K |
| Fluticasone Propionate Generic | 22 | 39 | Under 11 | $194 |
| Incruse Ellipta Umeclidinium Bromide | 21 | 21 | Under 11 | $7,319 |
| Creon Lipase/Protease/Amylase | 20 | 21 | Under 11 | $62K |
| Sodium Chloride 0.9 % Sodium Chloride | 19 | 19 | Under 11 | $1,002 |
| Azithromycin Generic | 18 | 18 | Under 11 | $169 |
| Zenpep Lipase/Protease/Amylase | 18 | 18 | Under 11 | $99K |
| Pantoprazole Sodium Generic | 14 | 16 | Under 11 | $23.25 |
| Dupixent Syringe Dupilumab | 14 | 14 | Under 11 | $52K |
| Prednisone Generic | 13 | 14 | Under 11 | $35.27 |
| Dupixent Pen Dupilumab | 12 | 12 | Under 11 | $45K |
Brand drugs: 352 claims; generic drugs: 220 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angelica E Honsberg $746 ($746 in general payments such as food, travel and fees) from 13 companies. The largest payer was Digestive Care, Inc. with $212.
| Company | Payments | Amount |
|---|---|---|
| Digestive Care, Inc. | 2 | $212 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $120 |
| Aimmune Therapeutics, Inc. | 4 | $94.97 |
| Electromed, Inc. ELMD | 6 | $66.34 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $45.99 |
| Insmed, Inc. INSM | 2 | $40.52 |
| Alcresta Therapeutics, Inc. | 1 | $31.44 |
| Tactile Systems Technology Inc TCMD | 1 | $27.61 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $26.95 |
| Abbvie Inc. ABBV | 1 | $24.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.